62 related articles for article (PubMed ID: 3430773)
1. [Pathologic change of serum albumin in chronic renal failure: human mercapt/nonmercaptoalbumin and endogenous drug binding inhibitor].
Tsuruta Y; Maeda K
Rinsho Byori; 1987 Sep; 35(9):975-80. PubMed ID: 3430773
[No Abstract] [Full Text] [Related]
2. Influences of haemodialysis on the binding sites of human serum albumin: possibility of an efficacious administration plan using binding inhibition.
Nishio T; Takamura N; Nishii R; Tokunaga J; Yoshimoto M; Kawai K
Nephrol Dial Transplant; 2008 Jul; 23(7):2304-10. PubMed ID: 18390890
[TBL] [Abstract][Full Text] [Related]
3. Organic acids and the uremic syndrome: protein metabolite hypothesis in the progression of chronic renal failure.
Niwa T
Semin Nephrol; 1996 May; 16(3):167-82. PubMed ID: 8734460
[TBL] [Abstract][Full Text] [Related]
4. Endogenous ligands that bind to serum albumin and renal failure.
Mabuchi H; Nakahashi H
Nephron; 1990; 55(1):81-2. PubMed ID: 2352581
[No Abstract] [Full Text] [Related]
5. Plasma protein binding of metbufen, a new non-steroid anti-inflammatory drug, in humans.
Brunner F; Zini R; Tillement JP
Int J Clin Pharmacol Ther Toxicol; 1984 Mar; 22(3):134-9. PubMed ID: 6201451
[TBL] [Abstract][Full Text] [Related]
6. [Comparative study of alminoprofene elimination in healthy subjects and in patients with renal or hepatic insufficiency (author's transl)].
Premel-Cabic A; Chaleil D; Bonniot R; Riberi P; Streichenberger G; Allain P
Therapie; 1981; 36(1):41-6. PubMed ID: 7233371
[No Abstract] [Full Text] [Related]
7. [Plasma binding of drugs in chronic renal failure].
Riant P; Barre J; Albengres E; Lemaire M; Tillement JP
Nephrologie; 1986; 7(3):89-93. PubMed ID: 3774085
[TBL] [Abstract][Full Text] [Related]
8. Binding of tiaprofenic acid to human sera and isolated serum proteins.
Nilsen OG; Storhaug A; Dale O
Arzneimittelforschung; 1985; 35(6):984-7. PubMed ID: 4026926
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms for covalent binding of benoxaprofen glucuronide to human serum albumin. Studies By tandem mass spectrometry.
Qiu Y; Burlingame AL; Benet LZ
Drug Metab Dispos; 1998 Mar; 26(3):246-56. PubMed ID: 9492388
[TBL] [Abstract][Full Text] [Related]
10. Retention of an albumin-bound furan dicarboxylic acid in patients with chronic renal failure or after a kidney transplant.
Costigan MG; Yaqoob M; Lindup WE
Nephrol Dial Transplant; 1996 May; 11(5):803-7. PubMed ID: 8671898
[TBL] [Abstract][Full Text] [Related]
11. Metabolism and kinetics of propylurofuranic acid in end-stage renal failure.
Shinzato T; Morita H; Maeda K
ASAIO J; 1994; 40(1):94-6. PubMed ID: 8186503
[No Abstract] [Full Text] [Related]
12. Benoxaprofen: plasma binding and binding interactions with some drugs and endogenous compounds.
Albengres E; Urien S; Kusmierek J; Tillement JP
Eur J Rheumatol Inflamm; 1982; 5(2):87-97. PubMed ID: 6806105
[TBL] [Abstract][Full Text] [Related]
13. Protein binding of itraconazole and fluconazole in patients with chronic renal failure.
Arredondo G; Martinez-Jorda R; Calvo R; Aguirre C; Suarez E
Int J Clin Pharmacol Ther; 1994 Jul; 32(7):361-4. PubMed ID: 7952798
[TBL] [Abstract][Full Text] [Related]
14. Separation of albumin-binding ligands present in uremic serum by high-performance affinity chromatography.
Mabuchi H; Nakahashi H
J Chromatogr; 1990 Aug; 529(2):424-30. PubMed ID: 2229260
[No Abstract] [Full Text] [Related]
15. A new procedure for the removal of protein bound drugs and toxins.
Stange J; Mitzner S; Ramlow W; Gliesche T; Hickstein H; Schmidt R
ASAIO J; 1993; 39(3):M621-5. PubMed ID: 8268613
[TBL] [Abstract][Full Text] [Related]
16. Clinical pharmacology of benoxaprofen.
Ridolfo AS; Carmichael RH; DeSante KA; Bergstrom RF; Rockhold FW; Nash JF; Fineberg SE
Eur J Rheumatol Inflamm; 1982; 5(2):98-112. PubMed ID: 7084287
[TBL] [Abstract][Full Text] [Related]
17. Levels of serum glycosaminoglycans in renal failure.
Mitsuhashi M; Mitsuhashi H; Yano S; Tsukada Y; Nojima Y; Naruse T
Res Commun Mol Pathol Pharmacol; 1998 Feb; 99(2):225-32. PubMed ID: 9583096
[TBL] [Abstract][Full Text] [Related]
18. Interaction of 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid, an inhibitor of plasma protein binding in uraemia, with human albumin.
Henderson SJ; Lindup WE
Biochem Pharmacol; 1990 Dec; 40(11):2543-8. PubMed ID: 2268372
[TBL] [Abstract][Full Text] [Related]
19. [Albumin metabolism in chronic renal insufficiency].
Kozlov VV; Rjabov SI
Z Gesamte Inn Med; 1981 Nov; 36(22):889-91. PubMed ID: 7342514
[TBL] [Abstract][Full Text] [Related]
20. Metabolic and pharmacokinetic studies with fenbufen in man.
Chiccarelli FS; Eisner HJ; Van Lear GE
Arzneimittelforschung; 1980; 30(4A):728-35. PubMed ID: 7192124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
